Clinical trial Recruiting at 1 site Interventional Ages 18 and up

CO2 flushing before TEVAR to lower brain embolisms

Official title: A Standard Carbon Dioxide Flushing Protocol to Reduce Air Embolization During Thoracic Endovascular Aortic Repair

Run by University of Bologna · NCT07734584 · Data updated 2026-11-12

This study tests a carbon dioxide pre-flush protocol before placing thoracic endografts to see if it reduces brain embolisms in adults with type B acute aortic syndrome or certain thoracic aneurysms.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorUniversity of Bologna
Academic / other
Locations4 sites (Bologna, Italy and 3 other locations)
StatusRecruiting
StartedJuly 15, 2025
Main results expectedJuly 15, 2028
Study endsJuly 15, 2028
Registry record updatedJuly 29, 2026
Trial IDNCT07734584 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with type B acute aortic syndrome or thoracic/thoracoabdominal aneurysms (Crawford I–IV) undergoing TEVAR.

Probably not a fit

Patients who require emergency treatment, have recent stroke/TIA, or have contraindications to DW-MRI may not benefit or be excluded from benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

FlushTEVAR is a multicenter, randomized, single-blind interventional study led by the University of Bologna. It compares a pre-implant CO2 endograft flushing sequence followed by saline flushing against standard flushing during thoracic endovascular aortic repair. The goal is to see whether this CO2 technique lowers periprocedural embolic events and cerebral infarctions. Eligible patients include adults with type B acute aortic syndrome or specific Crawford-classified aneurysms. The trial is coordinated across several Italian centers and aligns with a non-profit research model.

Why it matters

Potential benefit: If successful, the protocol could reduce brain embolic events and improve outcomes after TEVAR.

How similar studies have gone: Prior TEVAR studies show neurological complications can be mitigated by technique refinements; this CO2 flushing approach is exploratory and novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age is at least 18 years
* Present with type B acute aortic syndrome in the acute, subacute, or chronic phase
* Thoracic and thoracoabdominal aneurysms with Crawford extent I, II, III, or IV
* Written informed consent

Exclusion Criteria:

* Procedure performed using CO₂ angiography
* Endografts without a sheath is used
* Emergency endovascular treatment required
* Patient has experienced a stroke or TIA within the previous six months
* Proximal sealing zone is 0 or 1
* Any contraindication to DW-MRI
* Pregnancy or breastfeeding

Where it's running

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Italy, Italy
    Recruiting
  • A.S.S.T. Spedali Civili di Brescia
    Brescia, Italy, Italy
    Not yet recruiting
  • IRCCS Policlinico San Martino di Genova
    Genova, Italy, Italy
    Not yet recruiting
  • Azienda Ospedaliero-Universitaria di Padova
    Padova, Italy, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.